pembrolizumab,lenvatinib
merck,eisai
['hcc', 'bcsm', 'leap-002', 'lenva']
leap-002 trial misses primary end points, but data support role of lenvatinib monotherapy as soc in frontline hcc #hpbcsm #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.